Guillaume recently joined H1 as SVP of Clinical Strategy & Solution Design (Sept 1st), where he will be focused on building partnerships across the pharmaceutical industry and helping shape innovative AI and digital solutions for Clinical Development. Previously, Guillaume was VP of Operational Data Insights at Novo Nordisk, leading a team dedicated to data-driven decision-making and the development of StudyHub, an AI- and Clinical Ontology-powered platform. The team worked to improve how clinical trials are designed, planned, funded, and executed, turning AI-driven insights into real-world impact. Before Novo Nordisk, Guillaume spent 20 years at Novartis in a variety of leadership roles, including Head of Health Data Insights & Design in Clinical Operations. Throughout that time, he combined expertise across data, technology, and clinical operations to drive innovation, improve decision-making, and help shape new approaches to healthcare. Passionate about technology, data, and AI, Guillaume is always looking for practical ways to turn insights into meaningful results and patient outcome.
As agentic AI moves from demos to decisions, pharma leaders must decide what to build, what to buy, and where partnership creates advantage. This panel cuts through hype to debate ownership, governance, validation, and the real sources of competitive moat.